BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16505666)

  • 1. Invasive candidiasis in the intensive care unit.
    Ostrosky-Zeichner L; Pappas PG
    Crit Care Med; 2006 Mar; 34(3):857-63. PubMed ID: 16505666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungals in the ICU.
    Playford EG; Eggimann P; Calandra T
    Curr Opin Infect Dis; 2008 Dec; 21(6):610-9. PubMed ID: 18978529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
    Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM
    Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to antifungal agents in the critical care setting: problems and perspectives.
    Martins MD; Rex JH
    New Horiz; 1996 Aug; 4(3):338-44. PubMed ID: 8856751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bench-to-bedside review: Candida infections in the intensive care unit.
    Méan M; Marchetti O; Calandra T
    Crit Care; 2008; 12(1):204. PubMed ID: 18279532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Candida infections in children: the clinical characteristics and species distribution and antifungal susceptibility of Candida spp.
    Belet N; Ciftçi E; Aysev D; Güriz H; Uysal Z; Taçyildiz N; Atasay B; Doğu F; Kendirli T; Kuloğlu Z; Ince E; Doğru U
    Turk J Pediatr; 2011; 53(5):489-98. PubMed ID: 22272448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region.
    Hsueh PR; Graybill JR; Playford EG; Watcharananan SP; Oh MD; Ja'alam K; Huang S; Nangia V; Kurup A; Padiglione AA
    Int J Antimicrob Agents; 2009 Sep; 34(3):205-9. PubMed ID: 19409759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida prophylaxis and therapy in the ICU.
    Echeverria PM; Kett DH; Azoulay E
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.
    Bassetti M; Righi E; Tumbarello M; Di Biagio A; Rosso R; Viscoli C
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):875-85. PubMed ID: 17140362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candidemia in the critically ill patient.
    Picazo JJ; González-Romo F; Candel FJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S83-5. PubMed ID: 19013345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal therapy for neonatal candidiasis.
    Zaoutis T; Walsh TJ
    Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anidulafungin in the treatment of patients with invasive candidiasis.
    Kett DH; Cubillos GF
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.